Evidence map›Paper›PMID 27251162›Full record

ArticleIn vitro cellular & developmental biology. Animal2016

A role for the Wnt3a/β-catenin signaling pathway in the myogenic program of C2C12 cells.

S Thomas Abraham

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S Thomas AbrahamDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Campbell University, PO Box 1090, Buies Creek, NC, 27506, USA. abraham@campbell.edu.
Campbell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Wnt/β-catenin signaling pathway is a key regulator of embryonic development that was first identified in drosophila. More recent work has suggested a role for this pathway in mammalian, myogenesis but this process remains to be more completely elucidated. The current study was designed to investigate the role of the Wnt3a/β-catenin signaling module in C2C12 cell differentiation and myotube formation. Activation of the Wnt/β-catenin pathway in differentiating myoblasts, using lithium chloride supplementation, increased both the number and size of C2C12 myotubes. On the other hand, pharmacological inhibitors of Wnt/β-catenin signaling (IWR-1, XAV939) resulted in significant decreases in myotube length without affecting their numbers. In separate experiments, a neutralizing antibody to Wnt3a also reduced myotube length without affecting the number of myotubes formed during differentiation. Confocal imaging studies revealed that β-catenin was primarily localized in the cytoplasmic region of undifferentiated myoblasts and differentiation resulted in its enhanced expression in myotubes. Additionally, LiCl treatment resulted in enhanced expression of β-catenin in pre-differentiating myoblast cultures. These data suggest that Wnt3a/β-catenin signaling plays a critical role in C2C12 cell differentiation and provides an appropriate model for elucidating its functions in more detail.

Indexed as

Muscle DevelopmentWnt Signaling PathwayAnimalsAntibodies, MonoclonalAntibodies, Neutralizingbeta CateninCell DifferentiationCell LineCell ProliferationGlycogen Synthase Kinase 3Lithium ChlorideMiceMuscle Fibers, SkeletalTankyrasesWnt3A ProteinAntibodies, MonoclonalAntibodies, Neutralizingbeta CateninGlycogen Synthase Kinase 3Lithium ChlorideTankyrasesWnt3A ProteinC2C12 cellsIWR-1-endoMyotubesSkeletal muscle differentiationWnt signalingXAV939β-Catenin

Identifiers

PMID27251162
OpenAlexW2415582780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.